Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
This antibody is covered by our Worry-Free Guarantee.

Expression of selected transporters and tight junction proteins in brain capillaries of mice exposed to bilateral renal ischemia/reperfusion injury at the protein level. Brain capillaries were isolated from frozen brains of mice exposed to bilateral renal ischemia/reperfusion injury followed by protein extraction and Western blot (A). The protein content of Bcrp (Abcg2, ATP Binding Cassette Subfamily G Member 2) (B), Glut1 (Slc2a1, Solute Carrier Family 2 Member 1) (C), Mrp4 (Abcc4, ATP Binding Cassette Subfamily C Member 4) (D), and P-gp (Mdr1, Abcb1b ATP Binding Cassette Subfamily B Member1) (E) was normalized to β-actin and is shown as average of n = 3 with standard deviations. *p < 0.05, ***p < 0.001.
Image collected and cropped by CiteAb under a CC-BY license from the following publication: Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood-Brain Barrier in vivo and in vitro. Front Physiol (2020)

Biochemical characterization of rat liver subcellular fractions and Pgp localization in endolysosomal-enriched fractions. Rat liver subcellular fractionation was performed by low speed centrifugation and subsequent density gradient ultracentrifugation. Recovery and purity of the cell organelles from collected gradient fractions 1–10 (top to bottom) were analyzed by separation of equal protein amounts (5 µg) of each fraction and whole-cell homogenate (H) and post-nuclear supernatant (PNS) by SDS-PAGE and immunoblotting. Homogenate and PNS data were similar; thus, PNS is shown here for only some proteins. Endolysosomes were detected using the LAMP-2 and Rab7 marker proteins and the luminal lysosomal protease cathepsin D (CatD). EEA1 was used as a marker for early endosomes. The purity of the endolysosomal fractions was assessed by organelle markers for mitochondria (VDAC), canalicular plasma membrane (ABCB4), and ER (calnexin). (A) Representative Western blots showing the distribution of the different organelle protein markers and Pgp in the gradient fractions. Some fractions (mainly 2 and 3) contained low protein amounts and thus could not be characterized for the presence of all marker proteins for each individual gradient. Therefore, marker quantification in the gradient fractions was repeatedly performed for different fractionations. (B) Quantification of the protein band intensities for the marker proteins in the different gradient fractions. Immunoblotting revealed recovery of endolysosomal vesicles from the top of the gradient (fractions 1–4) and co-fractionation of Pgp in the enriched endolysosomal fractions (1–4). Fraction 1 was essentially free of canalicular plasma membrane contamination and mitochondria but contains remnants of ER. Mitochondria localized in fractions 7–10 and were clearly separated from endolysosomal markers. The ER marker calnexin was present in each fraction, with the lowest amount in endolysosomal fraction 1. Values are expressed as the percentage of total marker protein levels detected in all fractions combined (set to 100%). Data are presented as means ± SEM; the number of quantified Western blots (n) is shown below the graphs.
Image collected and cropped by CiteAb under a CC-BY license from the following publication: Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver. Cells (2022)

Expression and functional analysis of MDR1. (a, b) The expression of TUBB3 was investigated by real-time quantitative PCR and Western blotting in each cell line. Values represent mean ± SD. ∗P < 0.05, versus parental cell line. (c) Functional activity of MDR1 was analyzed by EFLUXX-ID Green Multidrug Resistance Assay. The left black curve shows unstained cells as a negative control. The right blue curve shows cells stained with EFLUXX-ID Green.
Image collected and cropped by CiteAb under a CC-BY license from the following publication: Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line. Anal Cell Pathol (Amst) (2018)



Product Details
Alternative Name |
ABCB1, CD243, P-glycoprotein 1 |
---|---|
Application |
ICC, IHC (FS), IHC (PS), IP |
Application Notes |
Flow Cytometry: cell permeabilization required. |
Clone |
C219 |
Crossreactivity |
Cross-reacts with a ~200kDa protein which migrates in the same position as myosin and with C-erbB2 protein (p185c-erbB2). |
Formulation |
Phosphate-buffered solution with BSA and 0.09% NaN3 |
Host |
Mouse |
Immunogen |
SDS-solubilized plasma membranes of an MDR (multidrug resistant) Chinese hamster ovary (CHO) cell line and a human cell line. |
Isotype |
IgG1κ |
Positive Control |
Cell lines: Appropriate drug-sensitive parental cell lines and their multidrug resistant derivatives prepared by the same methods as the test specimens can be used as control materials.Tissue: Human liver (positive staining detected along luminal surfaces of bile canaliculi) or human colon (positive staining localized to luminal surface of secretory epithelium) are recommended. |
Recommendation Dilutions/Conditions |
Immunohistochemistry (paraffin sections):- For optimal staining, the sections should be pretreated with an antigen unmasking solution.- The antibody may be diluted to ≥1:25 for biotin based detection systems.- For optimal staining, the primary antibody should be incubated 60 minutes at room temperature.Western Blot (1:50-1:100)Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
Species Reactivity |
Dog, Human, Mouse, Primate, Rat |
Specificity |
Recognizes an internal, highly conserved amino acid sequence (VQEALD and VQAALD) found in both protein isoforms, P-glycoprotein and MDR3 P-glycoprotein. |
UniProt ID |
P08183 |
Worry-free Guarantee |
This antibody is covered by our Worry-Free Guarantee. |
Handling & Storage
Handling |
Keep at +4°C. Do not freeze. |
---|---|
Short Term Storage |
+4°C |
Long Term Storage |
+4°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey: Strazielle, N., Blondel, S., et al.; Front. Pharmacol. 16, 1523819 (2025), Abstract
- The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models: Stasiak, P., Sopel, J., et al.; Int. J. Mol. Sci. 26, 1124 (2025), Abstract
- Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrier: Thomas, J. R., Frye, W. J. E., et al.; Fluids Barriers CNS 21, 27 (2024), Abstract
- Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.: Mahgoub, T. M., Jordan, E. J., et al.; Cancer Chemother. Pharmacol. 93, 427 (2024), Reactant(s): Human, Abstract
- Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer: W.K. Lee, et al.; Int. J. Mol. Med. 31, 101492 (2022), Application(s): WB / Reactant(s) Human, Abstract
- Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver.: Gericke, B., Wienböker, I., et al.; Cells 11, (2022), Application(s): WB / Reactant(s): Rat, Abstract
- The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells: Demeule, M., Charfi, C., et al.; Pharmaceutics 14, (2022), Abstract
- Megalencephalic leukoencephalopathy with subcortical cysts is a developmental disorder of the gliovascular unit.: Vivien, D., Estévez, R., et al.; Elife 10, (2021), Application(s): WB, Abstract
- Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.: Löscher, W., Noack, A., et al.; Fluids Barriers CNS 18, 36 (2021), Application(s): WB, Abstract
- Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter: Y. Mai, et al.; Mol. Pharm. 18, 1895 (2021), Abstract
- Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents: J. Lee, et al.; Pharmaceutics 13, 559 (2021), Abstract
- Hepatocyte polarity establishment and apical lumen formation are organized by Par3, Cdc42, and aPKC in conjunction with Lgl: Tocan, V., Hayase, J., et al.; J. Biol. Chem. 297, 101354 (2021), Abstract
- Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein: T. Nabekura, et al.; Biochem. Biophys. Rep. 21, 100727 (2020), Application(s): Western Blot, Abstract — Full Text
- Optimization of an Oral Mucosa in vitro Model Based on Cell Line TR146: G.C. Lin, et al.; Tissue Barriers 21, 1748459 (2020), Application(s): WB / Reactant(s) Human, Abstract
- Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood-Brain Barrier in vivo and in vitro.: Burek, M., Burmester, S., et al.; Front. Physiol. 11, 569881 (2020), Application(s): WB / Reactant(s): Mouse, Abstract
- Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats: N. Karimian Pour, et al.; Pharmaceutics 11, 624 (2019), Application(s): WB / Reactant(s) Rat, Abstract — Full Text
- Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells: Nanayakkara, A. K., Follit, C. A., et al.; Sci. Rep. 8, 967 (2018), Abstract
- Endotoxin Modulates the Expression of Renal Drug Transporters in HIV-1 Transgenic Rats: N. Karimian Pour, et al.; J. Pharm. Pharm. Sci. 21, 117s (2018), Application(s): WB, Abstract
- MicroRNA-655-3p regulates Echinacea purpureamediated activation of ABCG2: C. Awortwe, et al.; Xenobiotica 48, 1050 (2018), Abstract
- Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines: M.P. Ceballos, et al.; Toxicol. Lett. 289, 63 (2018), Abstract
- Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol: K. Mieszala, et al.; Oncol. Lett. 15, 5825 (2018), Application(s): ICC, ICC-IF, WB / Reactant(s) Mouse, Abstract — Full Text
- Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line: K. Yahiro, et al.; Anal. Cell. Pathol. (Amst.) 2018, 8987568 (2018), Application(s): WB in human leiomysarcoma cell line SK-LMS-2, Abstract — Full Text
- A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions: Szabo, E., Türk, D., et al.; PLoS One 13, e0190629 (2018), Abstract
- MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells: Kaehler, M., Ruemenapp, J., et al.; Oncotarget 8, 92018 (2017), Abstract
- Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide: Dodacki, A., Wortman, M., et al.; Sci. Rep. 7, 13393 (2017), Abstract
- Impact of Endotoxin on the Expression of Drug Transporters in the Placenta of HIV-1 Transgenic (HIV-Tg) Rats: R.H. Ghoneim, et al.; Eur. J. Pharm. Sci. 102, 94 (2017), Abstract — Full Text
- Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction: M. Kanda, et al.; PLoS One 11, e0156562 (2016), Application(s): Western blot, Abstract — Full Text
- Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells.: Fardel, O., Parmentier, Y., et al.; Pharmaceutics 9, (2016), Application(s): WB / Reactant(s): Human, Abstract
- Classical and atypical resistance of cancer cells as a target for resveratrol: Borska, S., Pedziwiatr, M., et al.; Oncol. Rep. 36, 1562 (2016), Abstract
- Effect of brefeldin A and castanospermine on resistant cell lines as supplements in anticancer therapy: Wojtowicz, K., Januchowski, R., et al.; Oncol. Rep. 35, 2896 (2016), Abstract
- Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats: Ghoneim, R. H., Piquette-Miller, M., et al.; Drug Metab. Dispos. 44, 709 (2016), Abstract
- Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay: Jouan, E., Le Vee, M., et al.; Pharmaceutics 8, (2016), Abstract
- Localized Down-regulation of P-glycoprotein by Focused Ultrasound and Microbubbles induced Blood-Brain Barrier Disruption in Rat Brain: Cho, H., Lee, H. Y., et al.; Sci. Rep. 6, 31201 (2016), Abstract
- Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis: Mahdi, Z. M., Synal-Hermanns, U., et al.; Mol. Pharmacol. 90, 23 (2016), Abstract
- Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines: R. Januchowski, et al.; Int. J. Biochem. Cell Biol. 78, 248 (2016), Application(s): Immunofluorescence, Abstract
- Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines: R. Januchowski, et al.; J. Ovarian Res. 9, 65 (2016), Application(s): Immunofluorescence analysis, human ovarian carcinoma cell line A2780, Abstract — Full Text
- Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier: H. Chapy, et al.; Br. J. Pharmacol. 173, 497 (2016), Abstract — Full Text
- Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines: K. Wojtowicz, et al.; Biomed. Pharmacother. 74, 49 (2015), Application(s): Western blot, Immunocytochemistry, Abstract
- Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure: D. Imrichova, et al.; Eur. J. Pharm. Sci. 77, 29 (2015), Application(s): Western Blot, Abstract
- Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1: Siegmund, W., Modess, C., et al.; Br J Clin Pharmacol 79, 501 (2015), Abstract
- Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis: W. Stremmel, et al.; FASEB J. 28, 3159 (2014), Abstract
- St. John’s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer’s disease mouse model-role of P-glycoprotein: A. Brenn, et al.; Brain Pathol. 24, 18 (2014), Application(s): IHC using mouse brain tissue, Abstract — Full Text
- Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone: Hung, C. C., Chiou, M. H., et al.; PLoS One 8, e59419 (2013), Abstract
- Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood–brain barrier permeability: F.E. O’Brien, et al.; Int. J. Neuropsychopharmacol. 16, 2259 (2013), Abstract
- P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study: M. Feldmann, et al.; Lancet Neurol. 12, 777 (2013), Application(s): IHC using brain tissue, Abstract
- MDR gene expression analysis of six drug-resistant ovarian cancer cell lines: Januchowski, R., Wojtowicz, K., et al.; BioMed Res. Int. 2013, 241763 (2013), Abstract
- Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells: Bhatia, P., Bernier, M., et al.; Xenobiotica 42, 748 (2012), Abstract
- Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression: Saubaméa, B., Cochois-Guégan, V., et al.; J. Cereb. Blood Flow Metab. 32, 81 (2012), Abstract
- Effects of rifampicin, dexamethasone, St. John’s Wort and Thyroxine on maternal and foetal expression of Abcb1 and organ distribution of talinolol in pregnant rats: Saljé, K., Lederer, K., et al.; Basic Clin. Pharmacol. Toxicol. 111, 99 (2012), Abstract
- Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2: André, P., Saubaméa, B., et al.; J. Cereb. Blood Flow Metab. 32, 1989 (2012), Abstract
- Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.: Clynes, M., Stordal, B., et al.; PLoS One 7, e40717 (2012), Reactant(s): Human, Abstract
- Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway: Fu, D., Wakabayashi, Y., et al.; PNAS 108, 1403 (2011), Abstract
- Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice: A. Brenn, et al.; Int. J. Alzheimers Dis. 2011, 690121 (2011), Application(s): IHC using mouse brain tissue, Abstract — Full Text
- The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii: I. Bottova, et al.; PLOS ONE 5, e10062 (2010), Abstract
- Effect of Variations in the Amounts of P-Glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the Human Small Intestine on PBPK Models for Predicting Intestinal First Pass: A. Bruyere, et al.; Mol. Pharm. 7, 1596 (2010), Abstract
- Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier: B. Poller, et al.; Cell. Mol. Neurobiol. 30, 63 (2010), Abstract
- Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin: S. Borska, et al.; Molecules 15, 857 (2010), Abstract
- Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro: von Wedel-Parlow, M., Wölte, P., et al.; J. Neurochem. 111, 111 (2009), Abstract
- ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes: Ismair, M. G., Häusler, S., et al.; Hepatology 49, 1673 (2009), Abstract
- Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice: Pennings, M., Hildebrand, R. B., et al.; Cardiovasc. Res. 76, 175 (2007), Abstract
- Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance: Surowiak, P., Materna, V., et al.; Breast Cancer Res. 7, R862 (2005), Abstract
- Characterization of ABC transporter ABCB1 expressed in human neural stem/progenitor cells: Islam, M. O., Kanemura, Y., et al.; FEBS Lett. 579, 3473 (2005), Abstract
- A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.: Glynn, S. A., Gammell, P., et al.; Br. J. Cancer 91, 1800 (2004), Application(s): WB / Reactant(s): Human, Abstract
- CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells: Chen, K. G., Sale, S., et al.; Mol. Pharmacol. 65, 906 (2004), Abstract
- Expression and Localization of P-glycoprotein in Human Heart: Effects of Cardiomyopathy: K. Meissner, et al.; J. Histochem. Cytochem. 50, 1351 (2002), Application(s): Immunostaining, Abstract — Full Text
- Permeability of porcine blood brain barrier to somatostatin analogues: Fricker, G., Nobmann, S., et al.; Br. J. Pharmacol. 135, 1308 (2002), Abstract
- Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone: R. Yumoto, et al.; Drug. Metab. Dispos. 29, 145 (2001), Abstract — Full Text
- Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. Multidrug transporters in the LLC-PK(1) cell line and its resistant counterpart: G. Decorti, et al.; Biochem. Pharmacol. 61, 61 (2001), Abstract
- Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis: F. Thevenod, et al.; J. Biol. Chem. 275, 1887 (2000), Abstract — Full Text
- Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart: A. Rosati, et al.; Anticancer Res. 20, 3403 (2000), Abstract
- Activation of the human P-glycoprotein ATPase by trypsin: S.L. Nuti, et al.; Biochemistry 39, 3424 (2000), Abstract
- Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity: M. Julien & P. Gros; Biochemistry 39, 4559 (2000), Abstract
- Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies: G.L. Scheffer, et al.; Cancer Res. 60, 5269 (2000), Abstract — Full Text
- Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response: I.O. Ng, et al.; Am. J. Clin. Pathol. 113, 355 (2000), Abstract
- P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries: M. Demeule, et al.; FEBS Lett. 466, 219 (2000), Abstract
- Interferon α2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype: M.H. Frank & S. Pomer; J. Cancer. Res. Clin. Oncol. 125, 117 (1999), Abstract
- Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport: E. Crivellato, et al.; Histochem. J. 31, 635 (1999), Abstract
- Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival: H. Yokoyama, et al.; Surg. Today 29, 1141 (1999), Abstract
- Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells: H. Wada, et al.; Exp. Hematol. 27, 99 (1999), Abstract
- Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein: J.M. van Den Elsen, et al.; PNAS 96, 13679 (1999), Abstract — Full Text
- A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin: S.M. Hahn, et al.; Int. J. Oncol. 14, 273 (1999), Abstract
- Transport of doxorubicin in mast cell granules and the effect of the calcium antagonist verapamil: L. Candussio, et al.; Anticancer Res. 19, 1101 (1999), Abstract
- Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin: K. Kawazu, et al.; Invest. Ophtalmol. Vis. Sci. 40, 1738 (1999), Abstract
- Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study: C. Dhooge & B. De Moerloose; Adv. Exp. Med. Biol. 457, 11 (1999), Abstract
- The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme: R. Durmaz, et al.; Clin. Neurol. Neurosurg. 101, 238 (1999), Abstract
- P-glycoprotein expression and prognostic value in acute myeloid leukemia: L. Senent, et al.; Haematologica 83, 783 (1998), Abstract
- MRP and MDR1 gene expression in primary breast carcinomas: M. Filipits, et al.; Clin. Cancer Res. 2, 1231 (1996), Abstract
- Methods to detect P-glycoprotein-associated multidrug resistance in patients’ tumors: consensus recommendations: W.T. Beck, et al.; Cancer Res. 56, 3010 (1996), Abstract
- Comparison of an immunoperoxidase sandwich” staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas”””: K. Toth, et al.; Am. J. Pathol. 140, 1009 (1992), Abstract
- Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies: A.H. Schinkel, et al.; Cancer Res. 51, 2628 (1991), Abstract
- A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines: H.S. Chan, et al.; Lab. Invest. 59, 870 (1988), Abstract
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies: N. Kartner, et al.; Nature 316, 820 (1985), Abstract
- New immunohistochemical sandwich” staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed: paraffin-embedded human tissues”””; K. Toth et al. Am. J. Pathol., 144 (227), 1994, Full Text
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form